Skip to main content
JUDGES SCIENTIFIC PLC logo

JUDGES SCIENTIFIC PLC — Investor Relations & Filings

Ticker · JDG ISIN · GB0032398678 LEI · 2138004EXWWPTW1JOL31 IL Manufacturing
Open in API
Filings indexed 618 across all filing types
Latest filing 2021-02-03 Director's Dealing
Country GB United Kingdom
Listing IL JDG

About JUDGES SCIENTIFIC PLC

https://www.judges.uk.com/

Judges Scientific PLC is a group focused on acquiring and developing a portfolio of scientific instrument businesses. The group's strategy combines corporate expansion through the acquisition of established, niche companies with fostering organic growth within its subsidiaries. These subsidiaries design and produce a wide range of specialized scientific instruments that are sold worldwide. The portfolio serves diverse markets, including higher education institutions, scientific research communities, manufacturers, and regulatory authorities. Key application areas for its instruments include materials science, life sciences (such as electrophysiology and microscopy), geosciences (geological core, soil, and rock analysis), fiber optics, and fire testing technology.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official notification filed under the RNS (Regulatory News Service) system, indicated by the 'RNS Number' and the closing statement referencing RNS and the FCA. The content explicitly details share purchases by 'Director/PDMR' (Persons Discharging Managerial Responsibilities), specifically the Group Finance Director and a Non-Executive Director. This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of 'Director's Dealing'. Therefore, the appropriate code is DIRS.
2021-02-03 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and contains a standard footer referencing RNS, the news service of the London Stock Exchange, which is approved by the FCA as a Primary Information Provider. The content explicitly states the 'Total Voting Rights' as of a specific date (29 January 2021) and confirms the total issued share capital. This type of announcement, detailing changes in the total number of shares or voting rights, is a mandatory regulatory disclosure. While it relates to share capital, it is presented as a general regulatory news service announcement rather than a formal 'Share Issue/Capital Change' (SHA) filing which usually details the transaction itself. Given the source (RNS) and the nature of the disclosure (Total Voting Rights update), the most appropriate classification is the general regulatory filing category, RNS.
2021-01-29 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document explicitly details a share transaction (sale of 50,000 ordinary shares) by the Chief Executive Officer (David Cicurel), who is a Person Discharging Managerial Responsibilities (PDMR). The filing is marked with an RNS Number (1949M) and contains contact information for brokers and the London Stock Exchange, indicating it is a regulatory disclosure concerning insider trading/director dealings. This directly matches the definition for Director's Dealing (DIRS). The document length is short (3693 chars), but the content is the primary disclosure itself, not an announcement of a separate report, thus ruling out RPA/RNS as the primary classification.
2021-01-19 English
Grant of Options
Share Issue/Capital Change Classification · 99% confidence The document is an official announcement released via RNS (RNS Number: 0597L, dated 08 January 2021) from Judges Scientific PLC. The content details the 'Grant of Options' to Executive Directors, which constitutes insider transactions/share dealings by management. While it involves directors, the primary nature is a regulatory disclosure about executive compensation/incentives via options, which often falls under insider dealing reports or general regulatory announcements. The detailed sections explicitly list transactions by 'person discharging managerial responsibilities' (David Cicurel, Bradley Ormsby, Mark Lavelle) regarding the 'Grant of Options'. This strongly aligns with the definition of Director's Dealing (DIRS) or potentially Remuneration Information (DEF 14A). However, since it is a specific transaction notification (grant of options) rather than a comprehensive remuneration report, and it is disseminated via RNS, it is most accurately classified as Director's Dealing (DIRS) or, if DIRS is too narrow, the general regulatory filing category (RNS). Given the explicit focus on director transactions, DIRS is the most specific fit among the options that cover insider activity. Since the document structure is a standard RNS press release format detailing insider transactions, DIRS is appropriate. If DIRS was not available, RNS would be the fallback.
2021-01-08 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Director/PDMR Shareholding' and details transactions involving shares by individuals discharging managerial responsibilities (CEO, Group Finance Director, COO) of Judges Scientific plc. This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing. The RNS Number format (9697K) and the mention of RNS confirm it is a regulatory disclosure, but the specific content points to DIRS over the general RNS category. The document length is relatively short (4762 chars), but it contains the full details of the transactions, not just an announcement of a report, thus it is not an RPA.
2021-01-07 English
Trading Statement and Notice of Final Results
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content is a 'Trading Statement and Notice of Final Results' for the year ended 31 December 2020, providing trading highlights and announcing the date for the full results release (23 March 2021). This is a regulatory announcement disseminated via the RNS system, but it is not the full financial report (10-K or IR) nor is it solely an announcement of a report's publication (RPA). Since it contains material, non-public trading updates and an announcement of future results, it fits best under the general 'Regulatory Filings' category (RNS) as it is a formal market communication disseminated through the official channel, rather than a specific financial statement type.
2021-01-07 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.